MyFinsight
Home
Blog
About
Short-term investments
$25,323K
(-57.92%↓ Y/Y)
Cash and cash
equivalents
$9,197K
(-14.72%↓ Y/Y)
Prepaid expenses and
other current assets
$883K
(-60.10%↓ Y/Y)
Accounts receivable and
unbilled receivable
$189K
(-64.07%↓ Y/Y)
Total current assets
$35,592K
(-51.70%↓ Y/Y)
Other assets
$927K
(131.17%↑ Y/Y)
Property and equipment,
net
$450K
(-39.43%↓ Y/Y)
Operating lease
right-of-use assets
$360K
(-59.96%↓ Y/Y)
Total assets
$37,329K
(-50.71%↓ Y/Y)
Total liabilities and
stockholders equity
$37,329K
(-50.71%↓ Y/Y)
Total stockholders
equity
$26,532K
(-54.73%↓ Y/Y)
Total liabilities
$10,797K
(-36.98%↓ Y/Y)
Accumulated deficit
-$451,607K
(-9.73%↓ Y/Y)
Accumulated other
comprehensive gain (loss)
-$62K
(-464.71%↓ Y/Y)
Additional paid-in capital
$478,194K
(1.71%↑ Y/Y)
Total current
liabilities
$10,797K
(-35.23%↓ Y/Y)
Common stock, 0.0001
par value, 150,000...
$7K
(0.00%↑ Y/Y)
Accrued liabilities
$6,354K
(-36.06%↓ Y/Y)
Accounts payable
$3,986K
(-33.68%↓ Y/Y)
Operating lease
liabilities
$457K
(-36.62%↓ Y/Y)
Back
Back
Balance Sheet
Cardiff Oncology, Inc. (CRDF)
Cardiff Oncology, Inc. (CRDF)
source: myfinsight.com